Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia (Q45815157)
Jump to navigation
Jump to search
scientific article published in December 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia |
scientific article published in December 2013 |
Statements
1 reference
Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia (English)
1 reference
Michael J Sorich
Wassana Sorich
1 December 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference